Story perspectives

Congo enrolls 250-plus in Gilead obeldesivir Ebola trial

By Drooid · Oct 4, 2026, 2:14 AM UTC · How we work

Summary

Congo Officials Enroll

Congo health officials have enrolled over 250 participants in a trial of Gilead antiviral obeldesivir.
ALIMA-coordinated trial enrolls people exposed to Bundibugyo Ebola virus within five days.
Dr. Godefroid Basara oversees 21-day monitoring and a day-42 follow-up call.
Dr. Guilavogui Jean Paul Yassa says obeldesivir is post-exposure prophylaxis, not a vaccine.
Outbreak has caused at least 8,300 cases and 4,000 deaths in seven provinces since mid-May.

Summary

Forces Burn Camp

Forces burned Kigonze camp’s Ebola transit centre, prompting 19,000 residents to flee.
One-fifth of 1,000 Ebola contacts in the camp were traced after the fire.
Health workers in Bunia protested wages, waving “No money, no data!” signs.
Marie-Celestin Karondwa, a UDPS official, died after being beaten and his house burned.
An Médecins Sans Frontières (MSF) doctor infected with Ebola was air-evacuated to Leiden University Center’s isolation unit in the Netherlands.

1 of 2

Congo Officials Enroll

Congo health officials have enrolled over 250 participants in a trial of Gilead antiviral obeldesivir.
ALIMA-coordinated trial enrolls people exposed to Bundibugyo Ebola virus within five days.
Dr. Godefroid Basara oversees 21-day monitoring and a day-42 follow-up call.
Dr. Guilavogui Jean Paul Yassa says obeldesivir is post-exposure prophylaxis, not a vaccine.
Outbreak has caused at least 8,300 cases and 4,000 deaths in seven provinces since mid-May.

1 / 2